Menu
GeneBe

rs41288015

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001134831.2(AHI1):c.2624-6A>G variant causes a splice region, splice polypyrimidine tract, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0206 in 1,605,156 control chromosomes in the GnomAD database, including 443 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.016 ( 37 hom., cov: 32)
Exomes 𝑓: 0.021 ( 406 hom. )

Consequence

AHI1
NM_001134831.2 splice_region, splice_polypyrimidine_tract, intron

Scores

2
Splicing: ADA: 0.0002084
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 0.540
Variant links:
Genes affected
AHI1 (HGNC:21575): (Abelson helper integration site 1) This gene is apparently required for both cerebellar and cortical development in humans. This gene mutations cause specific forms of Joubert syndrome-related disorders. Joubert syndrome (JS) is a recessively inherited developmental brain disorder with several identified causative chromosomal loci. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Oct 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.65).
BP6
Variant 6-135427313-T-C is Benign according to our data. Variant chr6-135427313-T-C is described in ClinVar as [Benign]. Clinvar id is 128325.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-135427313-T-C is described in Lovd as [Benign]. Variant chr6-135427313-T-C is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.0158 (2392/151688) while in subpopulation NFE AF= 0.0246 (1663/67582). AF 95% confidence interval is 0.0236. There are 37 homozygotes in gnomad4. There are 1150 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd at 37 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
AHI1NM_001134831.2 linkuse as main transcriptc.2624-6A>G splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant ENST00000265602.11

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
AHI1ENST00000265602.11 linkuse as main transcriptc.2624-6A>G splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant 1 NM_001134831.2 P2Q8N157-1

Frequencies

GnomAD3 genomes
AF:
0.0158
AC:
2393
AN:
151570
Hom.:
37
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00457
Gnomad AMI
AF:
0.00219
Gnomad AMR
AF:
0.0109
Gnomad ASJ
AF:
0.0116
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.00435
Gnomad FIN
AF:
0.0270
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.0246
Gnomad OTH
AF:
0.0110
GnomAD3 exomes
AF:
0.0156
AC:
3740
AN:
239992
Hom.:
41
AF XY:
0.0151
AC XY:
1969
AN XY:
130210
show subpopulations
Gnomad AFR exome
AF:
0.00439
Gnomad AMR exome
AF:
0.00973
Gnomad ASJ exome
AF:
0.0109
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00483
Gnomad FIN exome
AF:
0.0270
Gnomad NFE exome
AF:
0.0224
Gnomad OTH exome
AF:
0.0189
GnomAD4 exome
AF:
0.0211
AC:
30682
AN:
1453468
Hom.:
406
Cov.:
30
AF XY:
0.0204
AC XY:
14751
AN XY:
722744
show subpopulations
Gnomad4 AFR exome
AF:
0.00346
Gnomad4 AMR exome
AF:
0.0102
Gnomad4 ASJ exome
AF:
0.0100
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00556
Gnomad4 FIN exome
AF:
0.0260
Gnomad4 NFE exome
AF:
0.0243
Gnomad4 OTH exome
AF:
0.0177
GnomAD4 genome
AF:
0.0158
AC:
2392
AN:
151688
Hom.:
37
Cov.:
32
AF XY:
0.0155
AC XY:
1150
AN XY:
74178
show subpopulations
Gnomad4 AFR
AF:
0.00455
Gnomad4 AMR
AF:
0.0109
Gnomad4 ASJ
AF:
0.0116
Gnomad4 EAS
AF:
0.000193
Gnomad4 SAS
AF:
0.00436
Gnomad4 FIN
AF:
0.0270
Gnomad4 NFE
AF:
0.0246
Gnomad4 OTH
AF:
0.0109
Alfa
AF:
0.0218
Hom.:
13
Bravo
AF:
0.0137
Asia WGS
AF:
0.000577
AC:
2
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
Benign, no assertion criteria providedclinical testingJoint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+-- -
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Benign, no assertion criteria providedclinical testingGenome Diagnostics Laboratory, University Medical Center Utrecht-- -
Likely benign, no assertion criteria providedclinical testingGenetic Services Laboratory, University of Chicago-Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -
not provided Benign:2
Benign, criteria provided, single submitterclinical testingGeneDxMar 03, 2015- -
Likely benign, no assertion criteria providedclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center-- -
Joubert syndrome 3 Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 12, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Familial aplasia of the vermis Benign:1
Benign, criteria provided, single submitterclinical testingInvitaeFeb 01, 2024- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.65
Cadd
Benign
7.9
Dann
Benign
0.80

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.00021
dbscSNV1_RF
Benign
0.012
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs41288015; hg19: chr6-135748451; API